Cohort of Patients With Pelvic Gynecological Cancer: Constitution of a Collection of Biological Samples With Radioclinical Characterization

The management of pelvic gynecological cancers (PGC) is based on the determination of extension to guide treatments. The biology of the CGP is constantly evolving and personalized medicine adapted to this biology is currently in full development. For example, sequencing ovarian tumors can select patients who can benefit from anti-PARP therapy. There is therefore a need for patients to have biological samples of their tumor. Various studies on ovarian, endometrial and cervical cancer have sought to identify the factors predictive of recurrence of these cancers. The results obtained are very promising. This study will permit to collect biological samples and detailed clinical data that would allow to test hypotheses and develop a personalized medicine based on clinical and biological characteristics of patients.

NCT Number	NCT03622983
Lead Sponsor	Centre Hospitalier Intercommunal Creteil
Conditions	Pelvic Neoplasms, Endometriosis
Enrollment	500 participants
Start Date	2017-05-01
Primary Completion	2027-08 (estimated)
Study Completion	2037-08 (estimated)
Updated on ClinicalTrials.gov	2022-12-21